Results 11 to 20 of about 39,007 (262)

Impact of using a perioperative artificial endocrine pancreas in pancreatic resection

Annals of Gastroenterological Surgery, 2020
Aim Pancreatectomy causes both hyperglycemia, secondary to surgical stress, and pancreatic diabetes, which leads to difficult‐to‐control postoperative blood glucose levels.
Toshiaki Yoshimoto, Tetsuya Ikemoto, Yuji Morine, Satoru Imura, Yu Saito, Shinichiro Yamada, Katsuki Miyazaki, Yukako Takehara, Mitsuo Shimada   +8 more
doaj   +1 more source

Free-living use of artificial pancreas for children with type 1 diabetes: systematic review

Сахарный диабет, 2018
BACKGRAUND: A closed-loop glucose control system or ‘artificial pancreas’ consists of three components – a Continuous Glucose Monitor (CGM), infusion pumps to deliver hormone(s) and a sophisticated dosing algorithm to control hormone ...
Klemen Dovc, Gül Yeşiltepe Mutlu, Yury I. Philippov, Dmitry N. Laptev, Evgenia M. Patrakeeva, Lubov O. Chernilova, Alsu G. Zalevskaya, Marina V. Shestakova, Tadej Battelino   +8 more
doaj   +1 more source

Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes.

PLoS ONE, 2021
The artificial pancreas is a closed-loop insulin delivery system that automatically regulates glucose levels in individuals with type 1 diabetes. In-silico testing using simulation environments accelerates the development of better artificial pancreas ...
Haneen Alkhateeb, Anas El Fathi, Milad Ghanbari, Ahmad Haidar   +3 more
doaj   +1 more source

Structured Educational Program about Artificial Pancreas for Patients with Type 1 Diabetes Mellitus [PDF]

Egyptian Journal of Health Care
Background: Artificial pancreases are medical devices designed to help patients with type 1diabetes manage blood sugar levels by monitoring glucose automatically and delivering insulin as needed.
Sahar Mahmoud S. El Awady, Badria Abd Elshahed Ahmed El-Kattan, Amel Abd El - Aaziem Mohamed, Ons Said Mohamed El-Zayat   +3 more
doaj   +1 more source

Development platform for artificial pancreas algorithms.

PLoS ONE, 2020
Background and aimsAssessing algorithms of artificial pancreas systems is critical in developing automated and fault-tolerant solutions that work outside clinical settings.
Mohamed Raef Smaoui, Remi Rabasa-Lhoret, Ahmad Haidar   +2 more
doaj   +1 more source

Intraoperative glycemic control using an artificial endocrine pancreas in a patient with a recurrent pleural solitary fibrous tumor producing insulin-like growth factor 2: a case report

JA Clinical Reports, 2019
Background Non-islet cell tumor producing insulin-like growth factor 2 involves hypoglycemia. During tumor resection, intense fluctuation of blood glucose level may occur. An artificial endocrine pancreas has been reported as beneficial for patients with
Kenzaburou Sugimoto, Rina Tokitou, Mamoru Kadosaki, Mamoru Takeuchi   +3 more
doaj   +1 more source

A linear control of composite model for glucose insulin glucagon pump

Ain Shams Engineering Journal, 2019
Presently Type 1 diabetes is global issue and challenges for diabetes public for healthy life. Fully automatic artificial pancreas is well solution for diabetic patients to avoid the hyperglycemia/hypoglycemia as it provided the insulin/glucose when ...
Muhammad Farman, Muhammad Umer Saleem, M.F Tabassum, Aqeel Ahmad, M.O. Ahmad   +4 more
doaj   +1 more source

A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial

The Lancet: Digital Health, 2021
Summary: Background: For people with type 1 diabetes, there is currently no automated insulin delivery system that does not require meal input. We aimed to assess the efficacy of a novel faster-acting insulin aspart (Fiasp) plus pramlintide fully closed-
Michael A Tsoukas, MD, Dorsa Majdpour, Meng, Jean-François Yale, MD, Anas El Fathi, PhD, Natasha Garfield, MD, Joanna Rutkowski, Eng, Jennifer Rene, RN, Laurent Legault, MD, Ahmad Haidar, PhD   +8 more
doaj   +1 more source

Symposium 4: Insuline pumps in artificial páncreas systems

Revista de la Sociedad Argentina de Diabetes, 2020
Symposium 4: Biology and technology in the treatment of diabetes Insuline pumps in artificial páncreas systems By year 2021, insuline discover will reach a centenary.
Adrián Proietti
doaj   +1 more source

Characterization of Cyclic Olefin Copolymers for Insulin Reservoir in an Artificial Pancreas

Journal of Functional Biomaterials, 2023
Type-1 diabetes is one of the most prevalent metabolic disorders worldwide. It results in a significant lack of insulin production by the pancreas and the ensuing hyperglycemia, which needs to be regulated through a tailored administration of insulin ...
Norma Mallegni, Mario Milazzo, Caterina Cristallini, Niccoletta Barbani, Giulia Fredi, Andrea Dorigato, Patrizia Cinelli, Serena Danti   +7 more
doaj   +1 more source